Save
...
Paper 2
Biol 123
Coronaviruses
Save
Share
Learn
Content
Leaderboard
Share
Learn
Created by
Pierre Gasly
Visit profile
Cards (48)
SARS-CoV-2
Severe
Acute Respiratory Syndrome
Coronavirus
2
View source
Dr Muhammad
Munir
Email: muhammad.munir@lancaster.ac.uk, Phone: 01524
595083
, Office:
Furness B69
View source
Learning objectives
Introduction to
coronaviruses
and history of common
respiratory
coronaviruses
Molecular
biology of coronaviruses
Origin of coronaviruses especially
SARS-CoV-2
Entry and
molecular
replication
Viral
pathogenesis
Mutants
/variants
Diagnosis
Vaccines
Therapeutics
Immunity against
SARS-COV-2
View source
Sands P et al. N Engl J Med 2016;374:1281-1287. Major Emerging and Reemerging Infectious Diseases:
Beyond COVID-19
View source
First coronavirus discovered (IBV)
1931
View source
Discovery of HCoV-229E
1966
View source
Discovery of HCoV-OC43
1967
View source
Polyprotein
processing
1986
View source
Full genome sequenced
1987
View source
Targeted recombination
1992
View source
Reverse
genetics
1995
View source
EM of memb. vesicle
2000
View source
SARS-COV Pandemic
2002
View source
Discovery of HCoV-NL63
2003
View source
Discovery of HCoV-HKU1
2004
View source
MERS-COV Pandemic
2005
View source
SARS-COV-2 Pandemic
2008
View source
SARS-COV-2 Pandemic
2019
View source
SARS-COV-2 Pandemic
2020
View source
Coronaviruses Family
Nidovirales
Coronaviridae
Coronavirinae
Torovirinae
Torovirus
Bafinivirus
Alphacoronavirus
Betacoronavirus
Gammacoronavirus
Deltacoronavirus
View source
More than
500
CoVs have been identified in bats in
China
, with estimates of unknown bat CoV diversity reaching >5000
View source
SARS:
80098
cases, 774 total deaths (epidemic ended) (~
1%
case fatality)
View source
MERS:
2521
cases,
866
total deaths (infections still occurring) (35% case fatality rate)
View source
SARS-CoV-1/SARS
Spillover
reservoir unknown:
civet cats-cull
to break the chain
View source
SARS-CoV-2/CoVID-19
Spillover reservoir unknown,
Widespread
community transmission, Possible
abundant
asymptomatic/mild cases
View source
SARS-CoV-2
Comparison with other
Human
Coronaviruses
View source
SARS-COV-2 Genome
Encodes for
27
genes which are either: Structural,
Non-structural
, Accessory proteins
View source
SARS-COV-2 Genome
Single-stranded
, non-segmented, positive sense, ~
30
kb long genome
View source
Discontinuous replication
Bases for Diagnostics, CoV undergo
discontinuous transcription
, leading to
high recombination rates
View source
Error rate for RNA replication
Reduced by proof reading
Enzyme ExoN
(
NSP14
)
View source
Functions of Coronavirus Virion and Viral Proteins
S protein: Entry of SARS-COV-2 into cells, Host tropism,
Protective immune responses
(
vaccines
), Virulence
N protein: Component of nucleocapsid, Virus transcription efficiency, Protective immune responses (vaccines)
M protein: Most abundant amongst
structural proteins
, Assembly of
virus particles
E protein:
Smallest
amongst all the
structural proteins
, Virus assembly, and release
View source
Internal fusion peptide (IFP) S2'
Gate to Entry in the Cell:
Cleavability
and
Receptor
Interaction
View source
Omicron
Variant
View source
Delta
Variant
View source
Mechanism of SARS-CoV-2 Viral Entry
1.
Fusion
2.
Replication
3.
Assembly
4.
Release
View source
Mutations in the RBD of
Spike
proteins determine: New variants, Transmissibility, Virulence,
Vaccine escape
View source
Innate Immunity against SARS-COV-2
Dexamethasone
(Discovery
Trial
)
View source
Delta vs Omicron Variants:
Delta
variant,
Omicron
variant (70x)
View source
Adaptive Immunity against SARS-COV-2
CD+
T cells:
Helpers
Antibodies
(from
B
cells)
CD8
T cells:
Killers
View source
SARS-COV-2
causes
acute infections
that resolve/cure in most humans (~innate immunity)
View source
See all 48 cards